Central Bank & Trust’s Merck MRK Stock Holding History

Central Bank & Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.78M	Buy	29,437 +186	+0.6%	+$21.8K	0.54%	46
2026 Q1	$3.52M	Sell	29,251 -219	-0.7%	-$25.3K	0.55%	47
2025 Q4	$3.1M	Sell	29,470 -13,216	-31%	-$1.24M	0.48%	54
2025 Q3	$3.58M	Sell	42,686 -4,103	-9%	-$338K	0.56%	47
2025 Q2	$3.7M	Buy	46,789 +697	+2%	+$55.4K	0.61%	45
2025 Q1	$4.14M	Sell	46,092 -5,146	-10%	-$480K	0.69%	42
2024 Q4	$5.1M	Sell	51,238 -4,802	-9%	-$495K	0.77%	36
2024 Q3	$6.36M	Sell	56,040 -425	-0.8%	-$50.5K	0.88%	36
2024 Q2	$6.99M	Sell	56,465 -51	-0.1%	-$6.57K	0.97%	34
2024 Q1	$7.46M	Sell	56,516 -3,376	-6%	-$416K	1.06%	34
2023 Q4	$6.53M	Sell	59,892 -6,906	-10%	-$717K	1.01%	37
2023 Q3	$6.88M	Sell	66,798 -329	-0.5%	-$35.5K	1.2%	29
2023 Q2	$7.75M	Buy	67,127 +2,839	+4%	+$322K	1.31%	25
2023 Q1	$6.84M	Buy	64,288 +42,024	+189%	+$4.54M	1.22%	29
2022 Q4	$2.47M	Sell	22,264 -502	-2%	-$51.3K	0.47%	60
2022 Q3	$1.96M	Buy	22,766 +5,007	+28%	+$447K	0.42%	58
2022 Q2	$1.62M	Buy	17,759 +3,368	+23%	+$299K	0.33%	67
2022 Q1	$1.18M	Sell	14,391 -1,305	-8%	-$103K	0.19%	91
2021 Q4	$1.2M	Buy	15,696 +708	+5%	+$56.4K	0.19%	92
2021 Q3	$1.13M	Buy	14,988 +442	+3%	+$33.6K	0.18%	88
2021 Q2	$1.13M	Sell	14,546 -505	-3%	-$37.6K	0.18%	87
2021 Q1	$1.11M	Sell	15,051 -1,847	-11%	-$136K	0.19%	91
2020 Q4	$1.32M	Buy	16,898 +58	+0.3%	+$4.44K	0.23%	84
2020 Q3	$1.33M	Sell	16,840 -3,087	-15%	-$242K	0.25%	82
2020 Q2	$1.47M	Buy	19,927 +126	+0.6%	+$9.48K	0.29%	76
2020 Q1	$1.45M	Buy	19,801 +602	+3%	+$47.3K	0.35%	69
2019 Q4	$1.67M	Buy	19,199 +11,767	+158%	+$966K	0.33%	73
2019 Q3	$597K	Sell	7,432 -638	-8%	-$51.1K	0.13%	100
2019 Q2	$646K	Sell	8,070 -892	-10%	-$68.3K	0.15%	96
2019 Q1	$711K	Sell	8,962 -1,078	-11%	-$80.6K	0.16%	96
2018 Q4	$731K	Sell	10,040 -533	-5%	-$37.6K	0.18%	89
2018 Q3	$716K	Sell	10,573 -498	-4%	-$31.7K	0.17%	91
2018 Q2	$641K	Sell	11,071 -126	-1%	-$7.11K	0.16%	92
2018 Q1	$582K	Sell	11,197 -293	-3%	-$15.8K	0.15%	95
2017 Q4	$616K	Sell	11,490 -440	-4%	-$24.4K	0.15%	100
2017 Q3	$729K	Sell	11,930 -630	-5%	-$38.2K	0.18%	87
2017 Q2	$768K	Sell	12,560 -891	-7%	-$54.2K	0.2%	87
2017 Q1	$816K	Sell	13,451 -3,141	-19%	-$191K	0.21%	87
2016 Q4	$931K	Sell	16,592 -37	-0.2%	-$2.17K	0.25%	81
2016 Q3	$990K	Sell	16,629 -631	-4%	-$36.9K	0.28%	76
2016 Q2	$949K	Sell	17,260 -2,040	-11%	-$109K	0.27%	74
2016 Q1	$974K	Sell	19,300 -712	-4%	-$34.9K	0.27%	73
2015 Q4	$1.01M	Sell	20,012 -2,308	-10%	-$116K	0.29%	74
2015 Q3	$1.05M	Buy	22,320 +1,096	+5%	+$58.2K	0.35%	67
2015 Q2	$1.15M	Buy	21,224 +316	+2%	+$17.7K	0.37%	65
2015 Q1	$1.15M	Buy	20,908 +785	+4%	+$44.4K	0.38%	62
2014 Q4	$1.09M	Buy	20,123 +470	+2%	+$26.2K	0.37%	66
2014 Q3	$1.11M	Buy	19,653 +1,269	+7%	+$71.3K	0.42%	65
2014 Q2	$878K	Sell	18,384 -1,185	-6%	-$64.6K	0.34%	79
2014 Q1	$1.06M	Buy	19,569 +1,185	+6%	+$61.4K	0.41%	66
2013 Q4	$878K	Sell	18,384 -17,308	-48%	-$791K	0.34%	79
2013 Q3	$1.62M	Sell	35,692 -161	-0.4%	-$7.35K	0.73%	55
2013 Q2	$1.59M	Buy	+35,853	New	+$1.6M	0.76%	55

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

Central Bank & Trust's MRK Position: Q2 2026 in Review

Central Bank & Trust increased its Merck (MRK) stake by 0.64% in Q2 2026, buying an estimated $21.8K and bringing the position to 29,437 shares worth $3.78M. The position accounts for 0.54% of the portfolio, ranked #46.

Central Bank & Trust first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.75M in Q2 2023. 924 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Central Bank & Trust held 29,437 shares of Merck worth $3.78M as of Q2 2026.
Central Bank & Trust bought 186 Merck shares in Q2 2026, an estimated $21.8K.
Merck made up 0.54% of Central Bank & Trust's portfolio in Q2 2026, its #46 holding.
Central Bank & Trust first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Central Bank & Trust's Merck position peaked at $7.75M in Q2 2023.
924 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Central Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.